﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.irs.gov/efile" returnVersion="2010v3.2">
  <ReturnHeader binaryAttachmentCount="0">
    <Timestamp>2011-08-04T13:49:45-05:00</Timestamp>
    <TaxPeriodEndDate>2010-12-31</TaxPeriodEndDate>
    <PreparerFirm>
      <PreparerFirmBusinessName>
        <BusinessNameLine1>CARR RIGGS &amp; INGRAM LLC</BusinessNameLine1>
      </PreparerFirmBusinessName>
      <PreparerFirmUSAddress>
        <AddressLine1>4010 NW 25TH PLACE</AddressLine1>
        <City>GAINESVILLE</City>
        <State>FL</State>
        <ZIPCode>32606</ZIPCode>
      </PreparerFirmUSAddress>
    </PreparerFirm>
    <ReturnType>990</ReturnType>
    <TaxPeriodBeginDate>2010-01-01</TaxPeriodBeginDate>
    <Filer>
      <EIN>593471957</EIN>
      <Name>
        <BusinessNameLine1>FOUNDATION FOR APPLIED MOLECULAR EVOLUTION INC</BusinessNameLine1>
      </Name>
      <NameControl>FOUN</NameControl>
      <Phone>3522717005</Phone>
      <USAddress>
        <AddressLine1>PO BOX 13174</AddressLine1>
        <City>GAINESVILLE</City>
        <State>FL</State>
        <ZIPCode>32604</ZIPCode>
      </USAddress>
    </Filer>
    <Officer>
      <Name>STEVEN BENNER</Name>
      <Title>PRESIDENT</Title>
      <Phone>3522717005</Phone>
      <DateSigned>2011-05-09</DateSigned>
      <AuthorizeThirdParty>1</AuthorizeThirdParty>
    </Officer>
    <Preparer>
      <Name>FRANK WALTERS CPA</Name>
      <Phone>3523726300</Phone>
    </Preparer>
    <TaxYear>2010</TaxYear>
    <BuildTS>2016-02-24 21:20:13Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCount="7">
    <IRS990 documentId="RetDoc1038000001" referenceDocumentId="RetDoc1044400001">
      <NameOfPrincipalOfficerPerson>STEVEN BENNER</NameOfPrincipalOfficerPerson>
      <AddressPrincipalOfficerUS>
        <AddressLine1>PO BOX 13174</AddressLine1>
        <City>GAINESVILLE</City>
        <State>FL</State>
        <ZIPCode>32604</ZIPCode>
      </AddressPrincipalOfficerUS>
      <GrossReceipts>2915933</GrossReceipts>
      <GroupReturnForAffiliates>0</GroupReturnForAffiliates>
      <Organization501c3>X</Organization501c3>
      <WebSite>WWW.FFAME.ORG</WebSite>
      <TypeOfOrganizationCorporation>X</TypeOfOrganizationCorporation>
      <YearFormation>1997</YearFormation>
      <StateLegalDomicile>FL</StateLegalDomicile>
      <ActivityOrMissionDescription>THE FOUNDATION PROVIDES AN INNOVATIVE ENVIRONMENT TO HOST THE SCIENTIFIC AND TECHNOLOGICAL RESEARCH OF A SMALL GROUP OF SELECTED MOLECULAR AND LIFE SCIENTISTS TO MEET OPPORTUNITES IN COMMERCE AND MEDICINE.</ActivityOrMissionDescription>
      <NbrVotingMembersGoverningBody>5</NbrVotingMembersGoverningBody>
      <NbrIndependentVotingMembers>3</NbrIndependentVotingMembers>
      <TotalNbrEmployees>0</TotalNbrEmployees>
      <TotalNbrVolunteers>0</TotalNbrVolunteers>
      <TotalGrossUBI>0</TotalGrossUBI>
      <NetUnrelatedBusinessTxblIncome>0</NetUnrelatedBusinessTxblIncome>
      <ContributionsGrantsPriorYear>2189626</ContributionsGrantsPriorYear>
      <ContributionsGrantsCurrentYear>2831952</ContributionsGrantsCurrentYear>
      <ProgramServiceRevenuePriorYear>207860</ProgramServiceRevenuePriorYear>
      <ProgramServiceRevenueCY>81937</ProgramServiceRevenueCY>
      <InvestmentIncomePriorYear>1758</InvestmentIncomePriorYear>
      <InvestmentIncomeCurrentYear>2044</InvestmentIncomeCurrentYear>
      <OtherRevenuePriorYear>0</OtherRevenuePriorYear>
      <OtherRevenueCurrentYear>0</OtherRevenueCurrentYear>
      <TotalRevenuePriorYear>2399244</TotalRevenuePriorYear>
      <TotalRevenueCurrentYear>2915933</TotalRevenueCurrentYear>
      <GrantsAndSimilarAmntsPriorYear>0</GrantsAndSimilarAmntsPriorYear>
      <GrantsAndSimilarAmntsCY>0</GrantsAndSimilarAmntsCY>
      <BenefitsPaidToMembersPriorYear>0</BenefitsPaidToMembersPriorYear>
      <BenefitsPaidToMembersCY>0</BenefitsPaidToMembersCY>
      <SalariesEtcPriorYear>1240728</SalariesEtcPriorYear>
      <SalariesEtcCurrentYear>1718541</SalariesEtcCurrentYear>
      <TotalProfFundrsngExpPriorYear>0</TotalProfFundrsngExpPriorYear>
      <TotalProfFundrsngExpCY>0</TotalProfFundrsngExpCY>
      <TotalFundrsngExpCurrentYear>0</TotalFundrsngExpCurrentYear>
      <OtherExpensePriorYear>998369</OtherExpensePriorYear>
      <OtherExpensesCurrentYear>997417</OtherExpensesCurrentYear>
      <TotalExpensesPriorYear>2239097</TotalExpensesPriorYear>
      <TotalExpensesCurrentYear>2715958</TotalExpensesCurrentYear>
      <RevenuesLessExpensesPriorYear>160147</RevenuesLessExpensesPriorYear>
      <RevenuesLessExpensesCY>199975</RevenuesLessExpensesCY>
      <TotalAssetsBOY>980500</TotalAssetsBOY>
      <TotalAssetsEOY>1837796</TotalAssetsEOY>
      <TotalLiabilitiesBOY>561169</TotalLiabilitiesBOY>
      <TotalLiabilitiesEOY>1218490</TotalLiabilitiesEOY>
      <NetAssetsOrFundBalancesBOY>419331</NetAssetsOrFundBalancesBOY>
      <NetAssetsOrFundBalancesEOY>619306</NetAssetsOrFundBalancesEOY>
      <InfoInScheduleOPartIII>X</InfoInScheduleOPartIII>
      <MissionDescription>THE FOUNDATION PROVIDES AN INNOVATIVE ENVIRONMENT TO HOST THE SCIENTIFIC AND TECHNOLOGICAL RESEARCH OF A SMALL GROUP OF SELECTED MOLECULAR AND LIFE SCIENTISTS TO MEET OPPORTUNITES IN COMMERCE AND MEDICINE.</MissionDescription>
      <SignificantNewProgramServices>0</SignificantNewProgramServices>
      <SignificantChange>0</SignificantChange>
      <Expense>2368690</Expense>
      <Revenue>81937</Revenue>
      <Description>THE ORGANIZATION HAS THE FOLLOWING RESEARCH:1R01GM081527 ARTIFICIAL GENETIC SYSTEMSTHIS GRANT FUNDS EFFORTS TO DEVELOP THE FIELD OF "SYNTHETIC BIOLOGY", INVENTED IN PART IN THE BENNER LABORATORY. THE PRINCIPAL AIM OF SYNTHETIC BIOLOGISTS IS TO DEVELOP ARTIFICIAL CHEMICAL SYSTEMS THAT REPRODUCE THE "EMERGENT" PROPERTIES OF LIVING SYSTEMS, LEARNING ABOUT LIFE BY BUILDING IT "FROM THE GROUND UP".CONTINUED ON SCHEDULE O 1R01HG004647 CHEMISTRY TO IMPROVE HUMAN GENOMIC ARRAY ANALYSIS ARCHITECTURESTHIS PROJECT WILL FUND WORK TO APPLY INNOVATIVE CHEMICAL TOOLS TO DEVELOP SOLID-BASED SUPPORTS FOR HIGH THROUGHPUT GENOMIC ANALYSIS.3R01HG004647-02S1 CHEMISTRY TO IMPROVE HUMAN GENOMIC ARRAY ANALYSISARCHITECTURES (ARRA) AMERICAN RECOVERY AND RE-INVESTMENT ACT SUPPLEMENT TO PURCHASE INSTRUMENTS TO DEVELOP SOLID-BASED SUPPORTS FOR HIGH THROUGHPUT GENOMIC ANALYSIS, AND TO ENSURE THAT REAGENTS ASSOCIATED WITH THESE HAVE A SIGNIFICANT IMPACT ON THE ECONOMIC DEVELOPMENT OF THE UNITED STATES.1R01HG004831 NEAR TERM DEVELOPMENT OF REAGENTS AND ENZYMES FOR GENOME SEQUENCINGTHIS GRANT IS REQUESTED TO DEVELOP REAGENTS TO FACILITATE WHOLE GENOME ANALYSIS THROUGH A BINNING STRATEGY THAT COMBINES ARTIFICIALLY EXPANDED GENETIC INFORMATION SYSTEMS, SELF-AVOIDING MOLECULAR RECOGNITION SYSTEMS, SNAP2 DYNAMIC COMBINATORIAL CHEMISTRY, AND SEQUENCE THE BINNED SEQUENCES.3R01HG004831-02S1 NEAR TERM DEVELOPMENT OF REAGENTS AND ENZYMES FOR GENOME SEQUENCING, (ARRA)AMERICAN RECOVERY AND RE-INVESTMENT ACT SUPPLEMENT TO PURCHASE INSTRUMENTS TO DEVELOP REAGENTS TO FACILITATE WHOLE GENOME ANALYSIS THROUGH A BINNING STRATEGY THAT COMBINES ARTIFICIALLY EXPANDED GENETIC INFORMATION SYSTEMS, SELF-AVOIDING MOLECULAR RECOGNITION SYSTEMS, SNAP2 DYNAMIC COMBINATORIAL CHEMISTRY, AND SEQUENCING, AND TO ENSURE THAT REAGENTS ASSOCIATED WITH THESE HAVE A SIGNIFICANT IMPACT ON THE ECONOMIC DEVELOPMENT OF THE UNITED STATES.R01GM086617 BIOCHEM. &amp; PHARMA. STUDIES OF HUMAN MEMBRANE PROGESTERONE RECEPTORS. THIS GRANT WILL FUND STUDIES TO SIGNIFICANTLY EXPAND OUR UNDERSTANDING OF HOW HUMAN CELLS SENSE AND RESPOND TO HUMAN STEROIDS. 3R01GM086617-02S BIOCHEM. &amp; PHARMA. STUDIES OF HUMAN MEMBRANE PROGESTERONE RECEPTORS. AMERICAN RECOVERY &amp; REINVESTMET ACT SUPPLEMENT TO ASSIST IN THE PURCHASE OF A GEL DOCUMENTATION SYSTEM WITH CHEMILLUMINESCENCE TO PERFORM WESTERN BLOTS. R42HG004589-02STTR PHASE 2(SUBCONTRACT)MULTIPURPOSE REVERSIBLE TERMINATORS.THIS GRANT WILL FUND TECHNOLOGY TRANSFER FROM THE FOUNDATION FOR APPLIED MOLECULAR EVOLUTION TO FIREBIRD BIOMOLECULAR SCIENCES, LLC., TO BUILD A CATALOG OF REAGENTS AND KITS TO SUPPORT MULTIPLEXED NUCLEIC ACID ANALYSIS. 1R01AA017723 ALCOHOL METABOLISM, PRIMATE EVOLUTION, AND PALEOGENETICS. AN INCLUSIVE PARADIGM.THIS GRANT WILL FUND WORK APPLYING PALEOGENETICS AND GENOMICS TO FAMILIES OF GENES AND PROTEINS IMPORTANT IN HUMAN ALCOHOLISM, IN A COLLABORATIVE PROJECT WITH CRYSTALLOGRAPHERS AT INDIANA UNIVERSITY.HDTRA1-08-1-0052 SYNTHETIC SUBSTITUTES FOR DNATHIS GRANT FUNDS WORK DEVELOPING THE BASIC SCIENCE RELATING TO NUCLEIC ACID CHEMISTRY, ESPECIALLY AS IT RELATES TO COMPUTATIONAL ANALYSIS OF DNA STRUCTURE AND NUCLEIC ACID REPLACEMENTS OPERATING IN UNUSUAL ENVIRONMENTS. NNX08AO23G NASA PREBIOTIC ROUTES TO CARBOHYDRATES INVOLVING BORATEMINERALSTHIS GRANT FUNDS RESEARCH THAT TO UNDERSTAND HOW MINERALS MAY HAVE GUIDED THE REACTIVITY OF CARBONYL GROUPS TO GENERATE RIBOSE AND OTHER COMPONENTS OF RNA IN AN RNA-FIRST SCENARIO FOR THE ORIGIN OF LIFE.NASA ASTROBIOLOGY SUBCONTRACT FROM THE JET PROPULSION LAB TITANTHIS GRANT FUNDS RESEARCH THAT TO UNDERSTAND HOW TITAN MIGHT SERVE AS A MODEL FOR PREBIOTIC EARTH, WHETHER IT MIGHT CURRENTLY HOST LIFE THAT LIVES IN UNUSUAL ENVIRONMENTS, AND TO OTHERWISE INFORM NASA MISSIONS TO THIS MOON OF SATURN.NNX10AT28G NASA EXOBIOLOGY. LANDSCAPES IN CATALYTIC NUCLEIR ACIDS. THIS WORK WILL GENERATE QUANTITATIVE EXPERIMENTAL DATA TO DETERMINE WHERE TWO BIOPOLYMERS (DNA &amp; RNA) KNOWN TO BE ABLE TO SUPPORT BOTH GENETICS AND CATALYSIS LIE BETWEEN THESE EXTREMES. IT WILL FOCUS ON ONE PRODUCTIVE TYPE OF NUCLEIR ACID CATALYSIS (THE SZOSTAK-BARTEL-INOUYE LIGASE) AND ONE COUNTERPRODUCTIVE TYPE (BREAKER-JOYCE NUCLEASE), THE FIRST RNA, THE SECOND DNA.</Description>
      <TotalProgramServiceExpense>2368690</TotalProgramServiceExpense>
      <DescribedIn501C3 referenceDocumentId="RetDoc1039100001">1</DescribedIn501C3>
      <ScheduleBRequired referenceDocumentId="RetDoc1234500001">1</ScheduleBRequired>
      <PoliticalActivities>0</PoliticalActivities>
      <LobbyingActivities>0</LobbyingActivities>
      <DonorAdvisedFunds referenceDocumentId="RetDoc1040000001">0</DonorAdvisedFunds>
      <ConservationEasements referenceDocumentId="RetDoc1040000001">0</ConservationEasements>
      <CollectionsOfArt referenceDocumentId="RetDoc1040000001">0</CollectionsOfArt>
      <CreditCounseling referenceDocumentId="RetDoc1040000001">0</CreditCounseling>
      <TermOrPermanentEndowments referenceDocumentId="RetDoc1040000001">0</TermOrPermanentEndowments>
      <ReportLandBldgEquip referenceDocumentId="RetDoc1040000001">1</ReportLandBldgEquip>
      <ReportInvestOthSecurities referenceDocumentId="RetDoc1040000001">0</ReportInvestOthSecurities>
      <ReportProgRelInvest referenceDocumentId="RetDoc1040000001">0</ReportProgRelInvest>
      <ReportOtherAssets referenceDocumentId="RetDoc1040000001">0</ReportOtherAssets>
      <ReportOtherLiabilities referenceDocumentId="RetDoc1040000001">0</ReportOtherLiabilities>
      <ReportFin48Footnote referenceDocumentId="RetDoc1040000001">1</ReportFin48Footnote>
      <IndependentAuditFinancialStmt referenceDocumentId="RetDoc1040000001">1</IndependentAuditFinancialStmt>
      <ConsolidatedAuditFinancialStmt referenceDocumentId="RetDoc1040000001">0</ConsolidatedAuditFinancialStmt>
      <School>0</School>
      <ForeignOffice>0</ForeignOffice>
      <ForeignActivities>0</ForeignActivities>
      <MoreThan5000KToOrganizations>0</MoreThan5000KToOrganizations>
      <MoreThan5000KToIndividuals>0</MoreThan5000KToIndividuals>
      <ProfessionalFundraising>0</ProfessionalFundraising>
      <FundraisingActivities>0</FundraisingActivities>
      <Gaming>0</Gaming>
      <Hospital>0</Hospital>
      <GrantsToOrganizations>0</GrantsToOrganizations>
      <GrantsToIndividuals>0</GrantsToIndividuals>
      <ScheduleJRequired>0</ScheduleJRequired>
      <TaxExemptBonds>0</TaxExemptBonds>
      <ExcessBenefitTransaction referenceDocumentId="RetDoc1042800001">0</ExcessBenefitTransaction>
      <PriorExcessBenefitTransaction referenceDocumentId="RetDoc1042800001">0</PriorExcessBenefitTransaction>
      <LoanToOfficerOrDQP referenceDocumentId="RetDoc1042800001">0</LoanToOfficerOrDQP>
      <GrantToRelatedPerson referenceDocumentId="RetDoc1042800001">0</GrantToRelatedPerson>
      <BsnssRltnshpWithOrganization referenceDocumentId="RetDoc1042800001">1</BsnssRltnshpWithOrganization>
      <BsnssRltnshpThruFamilyMember referenceDocumentId="RetDoc1042800001">1</BsnssRltnshpThruFamilyMember>
      <OfficerEntityWithBsnssRltnshp referenceDocumentId="RetDoc1042800001">1</OfficerEntityWithBsnssRltnshp>
      <DeductibleNonCashContributions>0</DeductibleNonCashContributions>
      <DeductibleContributionsOfArt>0</DeductibleContributionsOfArt>
      <Terminated>0</Terminated>
      <PartialLiquidation>0</PartialLiquidation>
      <DisregardedEntity referenceDocumentId="RetDoc1043500001">0</DisregardedEntity>
      <RelatedEntity referenceDocumentId="RetDoc1043500001">1</RelatedEntity>
      <RelatedOrgControlledEntity>0</RelatedOrgControlledEntity>
      <TransactionRelatedEntity referenceDocumentId="RetDoc1043500001">0</TransactionRelatedEntity>
      <TransfersToExemptNonChrtblOrg referenceDocumentId="RetDoc1043500001">0</TransfersToExemptNonChrtblOrg>
      <ActivitiesConductedPartnership referenceDocumentId="RetDoc1043500001">0</ActivitiesConductedPartnership>
      <ScheduleORequired>1</ScheduleORequired>
      <NumberFormsTransmittedWith1096>3</NumberFormsTransmittedWith1096>
      <NumberW2GIncluded>0</NumberW2GIncluded>
      <ComplianceWithBackupWitholding>1</ComplianceWithBackupWitholding>
      <NumberOfEmployees>0</NumberOfEmployees>
      <UnrelatedBusinessIncome>0</UnrelatedBusinessIncome>
      <ForeignFinancialAccount>0</ForeignFinancialAccount>
      <ProhibitedTaxShelterTrans>0</ProhibitedTaxShelterTrans>
      <TaxablePartyNotification>0</TaxablePartyNotification>
      <NonDeductibleContributions>0</NonDeductibleContributions>
      <QuidProQuoContributions>0</QuidProQuoContributions>
      <Form8282PropertyDisposedOf>0</Form8282PropertyDisposedOf>
      <FundsToPayPremiums>0</FundsToPayPremiums>
      <PremiumsPaid>0</PremiumsPaid>
      <Form8899Filed>0</Form8899Filed>
      <IndoorTanningServices>0</IndoorTanningServices>
      <InfoInScheduleOPartVI>X</InfoInScheduleOPartVI>
      <NbrVotingGoverningBodyMembers>5</NbrVotingGoverningBodyMembers>
      <NumberIndependentVotingMembers>3</NumberIndependentVotingMembers>
      <FamilyOrBusinessRelationship>1</FamilyOrBusinessRelationship>
      <DelegationOfManagementDuties>0</DelegationOfManagementDuties>
      <ChangesToOrganizingDocs>0</ChangesToOrganizingDocs>
      <MaterialDiversionOrMisuse>0</MaterialDiversionOrMisuse>
      <MembersOrStockholders>0</MembersOrStockholders>
      <ElectionOfBoardMembers>0</ElectionOfBoardMembers>
      <DecisionsSubjectToApproval>0</DecisionsSubjectToApproval>
      <MinutesOfGoverningBody>1</MinutesOfGoverningBody>
      <MinutesOfCommittees>1</MinutesOfCommittees>
      <OfficerMailingAddress>0</OfficerMailingAddress>
      <LocalChapters>0</LocalChapters>
      <Form990ProvidedToGoverningBody>1</Form990ProvidedToGoverningBody>
      <ConflictOfInterestPolicy>1</ConflictOfInterestPolicy>
      <AnnualDisclosureCoveredPersons>1</AnnualDisclosureCoveredPersons>
      <RegularMonitoringEnforcement>1</RegularMonitoringEnforcement>
      <WhistleblowerPolicy>1</WhistleblowerPolicy>
      <DocumentRetentionPolicy>1</DocumentRetentionPolicy>
      <CompensationProcessCEO>1</CompensationProcessCEO>
      <CompensationProcessOther>1</CompensationProcessOther>
      <InvestmentInJointVenture>0</InvestmentInJointVenture>
      <UponRequest>X</UponRequest>
      <TheBooksAreInCareOf>
        <NameBusiness>
          <BusinessNameLine1>ROMAINE HUGHES</BusinessNameLine1>
        </NameBusiness>
        <TelephoneNumber>3522717005</TelephoneNumber>
        <AddressUS>
          <AddressLine1>PO BOX 13174</AddressLine1>
          <City>GAINESVILLE</City>
          <State>FL</State>
          <ZIPCode>32604</ZIPCode>
        </AddressUS>
      </TheBooksAreInCareOf>
      <Form990PartVIISectionA>
        <NamePerson>STEVEN BENNER</NamePerson>
        <Title>PRESIDENT</Title>
        <AverageHoursPerWeek>40.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <Officer>X</Officer>
        <ReportableCompFromOrganization>146458</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>STEPHEN CHAMBERLIN</NamePerson>
        <Title>BOD/ EX DIR</Title>
        <AverageHoursPerWeek>40.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <Officer>X</Officer>
        <ReportableCompFromOrganization>61386</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>NIGEL RICHARDS</NamePerson>
        <Title>BOARD MEMBER</Title>
        <AverageHoursPerWeek>1.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>1000</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>ANDREW ELLINGTON</NamePerson>
        <Title>BOARD MEMBER</Title>
        <AverageHoursPerWeek>1.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>BEVERLY A SANDERS</NamePerson>
        <Title>BOARD MEMBER</Title>
        <AverageHoursPerWeek>1.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>MATTHEW CARRIGAN</NamePerson>
        <Title>CHAIR OF THE EXEC COMMITTEE</Title>
        <AverageHoursPerWeek>1.00</AverageHoursPerWeek>
        <Officer>X</Officer>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <TotalReportableCompFromOrg>208844</TotalReportableCompFromOrg>
      <TotalReportableCompFrmRltdOrgs>0</TotalReportableCompFrmRltdOrgs>
      <TotalOtherCompensation>0</TotalOtherCompensation>
      <NumberIndividualsGT100K>1</NumberIndividualsGT100K>
      <FormersListed>0</FormersListed>
      <TotalCompGT150K>0</TotalCompGT150K>
      <CompensationFromOtherSources>0</CompensationFromOtherSources>
      <NumberOfContractorsGT100K>0</NumberOfContractorsGT100K>
      <GovernmentGrants>2827952</GovernmentGrants>
      <AllOtherContributions>4000</AllOtherContributions>
      <TotalContributions>2831952</TotalContributions>
      <ProgramServiceRevenue>
        <Description>REAGENT SALES</Description>
        <BusinessCode>541700</BusinessCode>
        <TotalRevenueColumn>43334</TotalRevenueColumn>
        <RelatedOrExemptFunctionIncome>43334</RelatedOrExemptFunctionIncome>
      </ProgramServiceRevenue>
      <ProgramServiceRevenue>
        <Description>STEVEN A BENNER CONTRA</Description>
        <BusinessCode>541700</BusinessCode>
        <TotalRevenueColumn>25336</TotalRevenueColumn>
        <RelatedOrExemptFunctionIncome>25336</RelatedOrExemptFunctionIncome>
      </ProgramServiceRevenue>
      <ProgramServiceRevenue>
        <Description>NUCLEIC ACIDS LICENSIN</Description>
        <BusinessCode>541700</BusinessCode>
        <TotalRevenueColumn>12015</TotalRevenueColumn>
        <RelatedOrExemptFunctionIncome>12015</RelatedOrExemptFunctionIncome>
      </ProgramServiceRevenue>
      <ProgramServiceRevenue>
        <Description>BOOK SALES</Description>
        <BusinessCode>541700</BusinessCode>
        <TotalRevenueColumn>1252</TotalRevenueColumn>
        <RelatedOrExemptFunctionIncome>1252</RelatedOrExemptFunctionIncome>
      </ProgramServiceRevenue>
      <TotalProgramServiceRevenue>81937</TotalProgramServiceRevenue>
      <InvestmentIncome>
        <TotalRevenueColumn>2044</TotalRevenueColumn>
        <ExclusionAmount>2044</ExclusionAmount>
      </InvestmentIncome>
      <TotalRevenue>
        <TotalRevenueColumn>2915933</TotalRevenueColumn>
        <RelatedOrExemptFunctionIncome>81937</RelatedOrExemptFunctionIncome>
        <UnrelatedBusinessRevenue>0</UnrelatedBusinessRevenue>
        <ExclusionAmount>2044</ExclusionAmount>
      </TotalRevenue>
      <CompCurrentOfficersDirectors>
        <Total>208844</Total>
        <ProgramServices>208844</ProgramServices>
      </CompCurrentOfficersDirectors>
      <OtherSalariesAndWages>
        <Total>1326592</Total>
        <ProgramServices>1150208</ProgramServices>
        <ManagementAndGeneral>176384</ManagementAndGeneral>
      </OtherSalariesAndWages>
      <OtherEmployeeBenefits>
        <Total>84263</Total>
        <ProgramServices>73309</ProgramServices>
        <ManagementAndGeneral>10954</ManagementAndGeneral>
      </OtherEmployeeBenefits>
      <PayrollTaxes>
        <Total>98842</Total>
        <ProgramServices>85993</ProgramServices>
        <ManagementAndGeneral>12849</ManagementAndGeneral>
      </PayrollTaxes>
      <FeesForServicesLegal>
        <Total>13325</Total>
        <ManagementAndGeneral>13325</ManagementAndGeneral>
      </FeesForServicesLegal>
      <FeesForServicesAccounting>
        <Total>39084</Total>
        <ManagementAndGeneral>39084</ManagementAndGeneral>
      </FeesForServicesAccounting>
      <FeesForServicesOther>
        <Total>2670</Total>
        <ManagementAndGeneral>2670</ManagementAndGeneral>
      </FeesForServicesOther>
      <Advertising>
        <Total>2750</Total>
        <ManagementAndGeneral>2750</ManagementAndGeneral>
      </Advertising>
      <OfficeExpenses>
        <Total>440826</Total>
        <ProgramServices>429400</ProgramServices>
        <ManagementAndGeneral>11426</ManagementAndGeneral>
      </OfficeExpenses>
      <InformationTechnology>
        <Total>18085</Total>
        <ProgramServices>3012</ProgramServices>
        <ManagementAndGeneral>15073</ManagementAndGeneral>
      </InformationTechnology>
      <Occupancy>
        <Total>175974</Total>
        <ProgramServices>160613</ProgramServices>
        <ManagementAndGeneral>15361</ManagementAndGeneral>
      </Occupancy>
      <Travel>
        <Total>17639</Total>
        <ProgramServices>16637</ProgramServices>
        <ManagementAndGeneral>1002</ManagementAndGeneral>
      </Travel>
      <ConferencesMeetings>
        <Total>5227</Total>
        <ProgramServices>5227</ProgramServices>
      </ConferencesMeetings>
      <Interest>
        <Total>78</Total>
        <ManagementAndGeneral>78</ManagementAndGeneral>
      </Interest>
      <DepreciationDepletion>
        <Total>171869</Total>
        <ProgramServices>159214</ProgramServices>
        <ManagementAndGeneral>12655</ManagementAndGeneral>
      </DepreciationDepletion>
      <Insurance>
        <Total>39737</Total>
        <ProgramServices>18162</ProgramServices>
        <ManagementAndGeneral>21575</ManagementAndGeneral>
      </Insurance>
      <OtherExpenses>
        <Description>EQUIPMENT RENTAL &amp; MAIN</Description>
        <Total>39665</Total>
        <ProgramServices>39665</ProgramServices>
      </OtherExpenses>
      <OtherExpenses>
        <Description>BUSINESS LICENSES/MEMBE</Description>
        <Total>19417</Total>
        <ProgramServices>11406</ProgramServices>
        <ManagementAndGeneral>8011</ManagementAndGeneral>
      </OtherExpenses>
      <OtherExpenses>
        <Description>SUBCONTRACTORS</Description>
        <Total>8000</Total>
        <ProgramServices>7000</ProgramServices>
        <ManagementAndGeneral>1000</ManagementAndGeneral>
      </OtherExpenses>
      <OtherExpenses>
        <Description>OTHER PERSONNEL EXPENSE</Description>
        <Total>2458</Total>
        <ManagementAndGeneral>2458</ManagementAndGeneral>
      </OtherExpenses>
      <OtherExpenses>
        <Description>BANK/CREDIT CARD FEES</Description>
        <Total>613</Total>
        <ManagementAndGeneral>613</ManagementAndGeneral>
      </OtherExpenses>
      <TotalFunctionalExpenses>
        <Total>2715958</Total>
        <ProgramServices>2368690</ProgramServices>
        <ManagementAndGeneral>347268</ManagementAndGeneral>
        <Fundraising>0</Fundraising>
      </TotalFunctionalExpenses>
      <CashNonInterestBearing>
        <EOY>69062</EOY>
      </CashNonInterestBearing>
      <SavingsAndTempCashInvestments>
        <BOY>369692</BOY>
        <EOY>729359</EOY>
      </SavingsAndTempCashInvestments>
      <PledgesAndGrantsReceivable>
        <BOY>117622</BOY>
        <EOY>365431</EOY>
      </PledgesAndGrantsReceivable>
      <AccountsReceivable>
        <EOY>21223</EOY>
      </AccountsReceivable>
      <PrepaidExpensesDeferredCharges>
        <BOY>2208</BOY>
      </PrepaidExpensesDeferredCharges>
      <LandBuildingsEquipmentBasis>1195577</LandBuildingsEquipmentBasis>
      <LandBldgEquipmentAccumDeprec>544064</LandBldgEquipmentAccumDeprec>
      <LandBuildingsEquipmentBasisNet>
        <BOY>490978</BOY>
        <EOY>651513</EOY>
      </LandBuildingsEquipmentBasisNet>
      <OtherAssetsTotal>
        <BOY>0</BOY>
        <EOY>1208</EOY>
      </OtherAssetsTotal>
      <TotalAssets>
        <BOY>980500</BOY>
        <EOY>1837796</EOY>
      </TotalAssets>
      <AccountsPayableAccruedExpenses>
        <BOY>43848</BOY>
        <EOY>293215</EOY>
      </AccountsPayableAccruedExpenses>
      <OtherLiabilities>
        <BOY>517321</BOY>
        <EOY>925275</EOY>
      </OtherLiabilities>
      <TotalLiabilities>
        <BOY>561169</BOY>
        <EOY>1218490</EOY>
      </TotalLiabilities>
      <FollowSFAS117>X</FollowSFAS117>
      <UnrestrictedNetAssets>
        <BOY>419331</BOY>
        <EOY>619306</EOY>
      </UnrestrictedNetAssets>
      <TotalNetAssetsFundBalances>
        <BOY>419331</BOY>
        <EOY>619306</EOY>
      </TotalNetAssetsFundBalances>
      <TotalLiabNetAssetsFundBalances>
        <BOY>980500</BOY>
        <EOY>1837796</EOY>
      </TotalLiabNetAssetsFundBalances>
      <ReconcilationRevenueExpenses>199975</ReconcilationRevenueExpenses>
      <InfoInScheduleOPartXII>X</InfoInScheduleOPartXII>
      <MethodOfAccountingAccrual>X</MethodOfAccountingAccrual>
      <AccountantCompileOrReview>0</AccountantCompileOrReview>
      <FSAudited>1</FSAudited>
      <AuditCommittee>1</AuditCommittee>
      <FinancialStatementSeparate>X</FinancialStatementSeparate>
      <FederalGrantAuditRequired>1</FederalGrantAuditRequired>
      <FederalGrantAuditPerformed>1</FederalGrantAuditPerformed>
    </IRS990>
    <IRS990ScheduleA documentId="RetDoc1039100001">
      <PubliclySupportedOrg170b1Avi>X</PubliclySupportedOrg170b1Avi>
      <GiftsGrantsContribReceived170>
        <CurrentTaxYearMinus4Years>1020390</CurrentTaxYearMinus4Years>
        <CurrentTaxYearMinus3Years>1009621</CurrentTaxYearMinus3Years>
        <CurrentTaxYearMinus2Years>1527886</CurrentTaxYearMinus2Years>
        <CurrentTaxYearMinus1Year>2189626</CurrentTaxYearMinus1Year>
        <CurrentTaxYear>2831952</CurrentTaxYear>
        <Total>8579475</Total>
      </GiftsGrantsContribReceived170>
      <Total170>
        <CurrentTaxYearMinus4Years>1020390</CurrentTaxYearMinus4Years>
        <CurrentTaxYearMinus3Years>1009621</CurrentTaxYearMinus3Years>
        <CurrentTaxYearMinus2Years>1527886</CurrentTaxYearMinus2Years>
        <CurrentTaxYearMinus1Year>2189626</CurrentTaxYearMinus1Year>
        <CurrentTaxYear>2831952</CurrentTaxYear>
        <Total>8579475</Total>
      </Total170>
      <PublicSupportTotal170>8579475</PublicSupportTotal170>
      <GrossInvestmentIncome170>
        <CurrentTaxYearMinus4Years>6589</CurrentTaxYearMinus4Years>
        <CurrentTaxYearMinus3Years>4286</CurrentTaxYearMinus3Years>
        <CurrentTaxYearMinus2Years>557</CurrentTaxYearMinus2Years>
        <CurrentTaxYearMinus1Year>1758</CurrentTaxYearMinus1Year>
        <CurrentTaxYear>2044</CurrentTaxYear>
        <Total>15234</Total>
      </GrossInvestmentIncome170>
      <TotalSupport>8594709</TotalSupport>
      <GrossReceiptsFromAdmissionsEtc>1899175</GrossReceiptsFromAdmissionsEtc>
      <PublicSupportPertcentage170>0.99820</PublicSupportPertcentage170>
      <PublicSupportPertcentPriorYear>0.99490</PublicSupportPertcentPriorYear>
      <ThirtyThreePercntTestsCY170>X</ThirtyThreePercntTestsCY170>
    </IRS990ScheduleA>
    <IRS990ScheduleB documentId="RetDoc1234500001">
      <ContributorInfo>
        <ContributorNumber>RESTRICTED</ContributorNumber>
        <ContributorNameBusiness>
          <BusinessNameLine1>RESTRICTED</BusinessNameLine1>
        </ContributorNameBusiness>
        <ContributorAddressUS>
          <AddressLine1>RESTRICTED</AddressLine1>
          <AddressLine2>RESTRICTED</AddressLine2>
          <City>RESTRICTED</City>
          <State>RESTRICTED</State>
          <ZIPCode>RESTRICTED</ZIPCode>
        </ContributorAddressUS>
        <AggregateContributions>RESTRICTED</AggregateContributions>
      </ContributorInfo>
    </IRS990ScheduleB>
    <IRS990ScheduleD documentId="RetDoc1040000001">
      <Equipment>
        <OtherCostOrOtherBasis>1195577</OtherCostOrOtherBasis>
        <Depreciation>544064</Depreciation>
        <BookValue>651513</BookValue>
      </Equipment>
      <TotalOfBookValueLandBuildings>651513</TotalOfBookValueLandBuildings>
      <OtherLiabilities>
        <Description>GRANT ADVANCES</Description>
        <Amount>925275</Amount>
      </OtherLiabilities>
      <TotalOfAmounts>925275</TotalOfAmounts>
      <TotalRevenue>2915933</TotalRevenue>
      <TotalExpenses>2715958</TotalExpenses>
      <ExcessOrDeficitForYear>199975</ExcessOrDeficitForYear>
      <TotalAdjustments>0</TotalAdjustments>
      <ExcessOrDeficitPerFS>199975</ExcessOrDeficitPerFS>
      <TotRevenueEtcAuditedFinclStmt>2915933</TotRevenueEtcAuditedFinclStmt>
      <RevenueNotRptdF990>0</RevenueNotRptdF990>
      <RevenueSubtotal>2915933</RevenueSubtotal>
      <RevenueNotRptdOnFinStmt>0</RevenueNotRptdOnFinStmt>
      <TotalRevenuePerForm990>2915933</TotalRevenuePerForm990>
      <TotExpensesEtcAuditedFinclStmt>2715958</TotExpensesEtcAuditedFinclStmt>
      <ExpensesNotRptdF990>0</ExpensesNotRptdF990>
      <ExpensesSubtotal>2715958</ExpensesSubtotal>
      <ExpensesNotRptdOnFinStmt>0</ExpensesNotRptdOnFinStmt>
      <TotalExpensesPerForm990>2715958</TotalExpensesPerForm990>
      <Form990ScheduleDPartXIV>
        <Identifier>DESCRIPTION OF UNCERTAIN TAX POSITIONS UNDER FIN 48:</Identifier>
        <ReturnReference>PART X:</ReturnReference>
        <Explanation>THE FOUNDATION FOLLOWS ACCOUNTING REQUIREMENTS ASSOCIATED WITH UNCERTAINTY IN INCOME TAXES USING THE PROVISIONS OF FINANCIAL ACCOUNTING STANDARDS BOARD (FASB) ASC 740, INCOME TAXES. USING THAT GUIDANCE, TAX POSITIONS INITIALLY NEED TO BE RECOGNIZED IN THE FINANCIAL STATEMENTS WHEN IT IS MORE-LIKELY-THAN-NOT THAT THE POSITIONS WILL BE SUSTAINED UPON EXAMINATION BY THE TAX AUTHORITIES. IT ALSO PROVIDES GUIDANCE FOR DERECOGNITION, CLASSIFICATION, INTEREST AND PENALTIES, ACCOUNTING IN INTERIM PERIODS, DISCLOSURE AND TRANSITION. AS OF DECEMBER 31, 2010, THE FOUNDATION HAS NO UNCERTAIN TAX POSITIONS THAT QUALIFY FOR EITHER RECOGNITION OR DISCLOSURE IN THE FINANCIAL STATEMENTS.</Explanation>
      </Form990ScheduleDPartXIV>
    </IRS990ScheduleD>
    <IRS990ScheduleL documentId="RetDoc1042800001">
      <Form990ScheduleLPartIV>
        <NameOfInterestedPerson>
          <NameBusiness>
            <BusinessNameLine1>NUCLEIC ACIDS LICENSING LLC</BusinessNameLine1>
          </NameBusiness>
        </NameOfInterestedPerson>
        <Relationship>OWNER</Relationship>
        <AmountOfTransaction>12015</AmountOfTransaction>
        <DescriptionOfTransaction>CONTRACT REVENUE</DescriptionOfTransaction>
        <SharingOfRevenues>0</SharingOfRevenues>
      </Form990ScheduleLPartIV>
      <Form990ScheduleLPartIV>
        <NameOfInterestedPerson>
          <NamePerson>STEVEN BRENNER</NamePerson>
        </NameOfInterestedPerson>
        <Relationship>PRESIDENT</Relationship>
        <AmountOfTransaction>17337</AmountOfTransaction>
        <DescriptionOfTransaction>CONTRACT REVENUE</DescriptionOfTransaction>
        <SharingOfRevenues>0</SharingOfRevenues>
      </Form990ScheduleLPartIV>
    </IRS990ScheduleL>
    <IRS990ScheduleO documentId="RetDoc1044400001">
      <GeneralExplanation>
        <Identifier>FORM 990, PART VI, SECTION A, LINE 2</Identifier>
        <Explanation>RELATED PARTY INFORMATION AMONG OFFICERS STEVEN BENNER- PRESIDENT BEVERLY SANDERS- DIRECTOR MARRIED</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <Identifier>FORM 990, PART VI, SECTION B, LINE 11</Identifier>
        <Explanation>A COPY OF THE FORM 990 WILL BE PROVIDED TO THE GOVERNING BODY BEFORE IT IS FILED. IT WILL BE REVIEWED AND ANY NECESSARY CHANGES WILL BE MADE.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <ReturnReference>FORM 990, PART VI, SECTION B, LINE 12C</ReturnReference>
        <Explanation>.THE BOARD ADDRESS THEIR CONFLICTS OF INTEREST THROUGHOUT THE YEAR AS THE NEED ARISES</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <ReturnReference>FORM 990, PART VI, SECTION B, LINE 15</ReturnReference>
        <Explanation>A BOARD MEETING IS CALLED TO REVIEW PERFORMANCE OF THE PRIOR YEAR. BOARD MEMBERS DETERMINE ANY INCREASE AND VOTE ON THE INCREASE DETERMINED. THE APPLICABLE INCREASE IS APPLIED ONCE IT IS VOTED ON AND APPROVED BY THE BOARD.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <ReturnReference>FORM 990, PART VI, SECTION C, LINE 18</ReturnReference>
        <Explanation>GOVERNING DOCUMENTS ARE MADE AVAILABLE TO THE PUBLIC UPON REQUEST.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <ReturnReference>FORM 990, PART VI, SECTION C, LINE 19</ReturnReference>
        <Explanation>THE BOARD ADDRESSES THEIR CONFLICTS OF INTEREST THROUGHOUT THE YEAR AS THE NEED ARISES.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <Identifier>DESCRIPTION OF OTHER EXPENSES THAT EXCEED 10% OF TOTAL FUNCTIONAL EXPENSES</Identifier>
        <ReturnReference>FORM 990 PART IV, LINE 24F</ReturnReference>
        <Explanation>THE FOUNDATION INCURRED $422,172.73 OF LABORATORY SUPPLIES COSTS.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <Explanation>THE PROCESS FOR THE REVIEW AND OVERSIGHT OF THE AUDIT HAS REMAINED THE SAME.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <ReturnReference>FORM 990, PAGE 5, LINE 2A</ReturnReference>
        <Explanation>THE ORGANIZATION LEASES ALL EMPLOYEES FROM OASIS OUTSOURCING AND ALL WAGES ARE REPORTED BY OASIS OUTSOURCING. OASIS OUTSOURCING HAS NO AUTHORITATIVE DUTIES WITH REGARD TO THE ORGANIZATION.</Explanation>
      </GeneralExplanation>
    </IRS990ScheduleO>
    <IRS990ScheduleR documentId="RetDoc1043500001">
      <Form990ScheduleRPartIV>
        <NameOfRelatedOrg>
          <BusinessNameLine1>FIREBIRD BIOMOLECULAR SCIENCES LLC</BusinessNameLine1>
        </NameOfRelatedOrg>
        <AddressUS>
          <AddressLine1>2153 SE HAWTHORNE RD 116</AddressLine1>
          <City>GAINESVILLE</City>
          <State>FL</State>
          <ZIPCode>32641</ZIPCode>
        </AddressUS>
        <EIN>900355722</EIN>
        <PrimaryActivity>RESEARCH</PrimaryActivity>
        <LegalDomicileState>FL</LegalDomicileState>
        <DirectControllingEntityNA>N/A</DirectControllingEntityNA>
        <TypeOfEntity>C</TypeOfEntity>
      </Form990ScheduleRPartIV>
      <Form990ScheduleRPartIV>
        <NameOfRelatedOrg>
          <BusinessNameLine1>NUCLEIC ACIDS LICENSING LLC</BusinessNameLine1>
        </NameOfRelatedOrg>
        <AddressUS>
          <AddressLine1>1501 NW 68TH TERRACE</AddressLine1>
          <City>GAINESVILLE</City>
          <State>FL</State>
          <ZIPCode>32605</ZIPCode>
        </AddressUS>
        <EIN>202709991</EIN>
        <PrimaryActivity>RESEARCH</PrimaryActivity>
        <LegalDomicileState>FL</LegalDomicileState>
        <DirectControllingEntityNA>N/A</DirectControllingEntityNA>
        <TypeOfEntity>C</TypeOfEntity>
      </Form990ScheduleRPartIV>
      <ReceiptOfIntAnnRentsRoyalties>0</ReceiptOfIntAnnRentsRoyalties>
      <GiftGrantOrCapContrToOtherOrg>0</GiftGrantOrCapContrToOtherOrg>
      <GiftGrantOrCapContrFrOtherOrg>0</GiftGrantOrCapContrFrOtherOrg>
      <LoansOrGuaranteesToOtherOrg>0</LoansOrGuaranteesToOtherOrg>
      <LoansOrGuaranteesFromOtherOrg>0</LoansOrGuaranteesFromOtherOrg>
      <SaleOfAssetsToOtherOrg>0</SaleOfAssetsToOtherOrg>
      <PurchaseOfAssetsFromOtherOrg>0</PurchaseOfAssetsFromOtherOrg>
      <ExchangeOfAssets>0</ExchangeOfAssets>
      <RentalOfFacilitiesToOtherOrgs>0</RentalOfFacilitiesToOtherOrgs>
      <RentalOfFacilitiesFrOtherOrgs>0</RentalOfFacilitiesFrOtherOrgs>
      <PerformOfServicesForOtherOrgs>0</PerformOfServicesForOtherOrgs>
      <PerformOfServicesByOtherOrgs>0</PerformOfServicesByOtherOrgs>
      <SharingOfFacilities>1</SharingOfFacilities>
      <SharingOfPaidEmployees>0</SharingOfPaidEmployees>
      <ReimbursementPaidToOtherOrg>0</ReimbursementPaidToOtherOrg>
      <ReimbursementPaidByOtherOrg>0</ReimbursementPaidByOtherOrg>
      <OtherTransferToOtherOrg>0</OtherTransferToOtherOrg>
      <OtherTransferFromOtherOrg>0</OtherTransferFromOtherOrg>
    </IRS990ScheduleR>
  </ReturnData>
</Return>